n-methyladenosine has been researched along with Gastrointestinal Stromal Tumors in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ding, J; Qian, K; Xia, X; Xu, W | 1 |
Bian, Y; Cui, Z; Gao, Z; He, Z; Li, B; Li, C; Li, F; Li, X; Li, Z; Liu, Z; Sun, H; Wang, L; Wang, N; Wang, Z; Xu, H; Xu, Z; Yang, L; Yang, Y; Zhang, D | 1 |
2 other study(ies) available for n-methyladenosine and Gastrointestinal Stromal Tumors
Article | Year |
---|---|
Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
Topics: Adenosine; Disease Progression; Gastrointestinal Stromal Tumors; Humans; Methyltransferases; MicroRNAs | 2022 |
N
Topics: Animals; Autophagy; Autophagy-Related Protein 5; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Methyltransferases; Mice; RNA-Binding Proteins; Ubiquitin-Specific Proteases | 2023 |